Targeting hepatic arginine metabolism for treatment of metabolic diseases
— Background
Over 30% of adults in the world are overweight or obese. Lifestyle management has proven to be impractical and ineffective in real-life settings and there are no current treatments available for metabolic disease.
Technology Summary
Pharmacological or genetic activation of the Arginine…
